Low Risk Myelodysplastic Syndrome
4 clinical trials · Condition
◉ Watch Low Risk Myelodysplastic Syndrome
| Record | Firm | Date |
|---|---|---|
| A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome (NCT04718844) | Silence Therapeutics plc | 2021-04-14 |
| Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124 (NCT04176653) | Silence Therapeutics plc | 2019-08-20 |
| Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes (NCT03824080) | GWT-TUD GmbH | 2018-12-20 |
| Pre-myeloid Cancer and Bone Marrow Failure Clinic Study (NCT02958462) | Mayo Clinic | 2017-01-16 |
Track Low Risk Myelodysplastic Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.